New Two-Pronged attack on tough lung cancers shows promise
NCT ID NCT07393555
Summary
This study is for people with advanced non-small cell lung cancer that has specific gene changes and has stopped responding to prior treatments. It will test whether two newer targeted drugs, given alone or together, can control the cancer better than standard options. The goal is to see if the combination helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV LUNG CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.